Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
ANTABIO logo — Developing Tomorrow's Antibacterials

ANTABIO

Developing Tomorrow's Antibacterials

Founded 2009 France France 25 employees Series B Total: $52.23M Biotechnology, Life Sciences +1

General Information

Company Name ANTABIO
Founded Year 2009
Location France France +1
Employees 25
Industries Biotechnology, Life Sciences, Medical Devices
Funding Stage Series B
Social

Get notified when ANTABIO moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ANTABIO

Antabio is a privately-held clinical-stage biopharmaceutical company founded in 2009, with a focus on developing novel and highly differentiated antibacterial treatments for drug-resistant infections. The company operates in the biotechnology, life sciences, and medical devices industries and is based in France. Antabio recently secured a significant €25.00M Series B investment on 12 December 2023. The investment was led by a consortium of prominent investors including BNP Paribas Developpement, European Innovation Council, Turenne Capital, AMR Action Fund, IRDI SORIDEC Gestion, and Christophe Ricard. Antabio's focus on combating infections caused by CDC and WHO critical priority pathogens underscores its commitment to addressing pressing global health challenges. For more information, visit Antabio's website at www.antabio.com and follow them on Twitter at @antabio.

Taxonomy: biopharmaceutical, antibacterial treatments, drug-resistant infections, metalloenzymes inhibitors, bacterial Metallo ß-lactamases, carbapenem combination, drug discovery, drug development, antibiotic adjuvant, nosocomial infections, clinical-stage, Wellcome Trust Seeding Drug Discovery Award, Labege, France

Funding Rounds & Investors (16)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 6
Investor Investor Investor Investor
•••• •••• 		12 Dec 2023
Grant •••••• 1
Investor
15 Jun 2022
Grant •••••• - 16 Mar 2021
Grant •••••• 1
Investor
02 Jan 2020
Series A •••••• - 12 Jul 2018

View All 16 Funding Rounds

ANTABIO Alternatives & Competitors

ANTABIO vs
Sealife PHARMA® GMBH
Sealife PHARMA® GMBH

Pioneering breakthroughs in marine biochemistry to combat drug-resistant infections and advance the...

Seed
Biotechnology, Health Care
Compare ANTABIO vs Sealife PHARMA® GMBH
ANTABIO vs
AGILeBiotics B.V.
AGILeBiotics B.V. The Netherlands

We are passionately translating innovation into novel antibiotics for the treatment of multidrug-res...

Seed
1 employees
Biotechnology, Health Care
Compare ANTABIO vs AGILeBiotics B.V.
ANTABIO vs
ContraFect Corp
ContraFect Corp United States

...focused on discovering & developing differentiated biologic therapies for life-threatening, drug-...

Post Ipo Equity
10 employees
Biotechnology, Health Care
Compare ANTABIO vs ContraFect Corp

FAQ About ANTABIO

Developing Tomorrow's Antibacterials
ANTABIO was founded in 2009.
ANTABIO is headquartered in France.
ANTABIO operates in the following industries: Biotechnology, Life Sciences, Medical Devices.
ANTABIO has approximately 25 employees.
ANTABIO has completed 16 funding rounds, raising a total of $52.23M. The latest funding stage is Series B.
Top alternatives and competitors to ANTABIO include Sealife PHARMA® GMBH, AGILeBiotics B.V., ContraFect Corp, Venatorx Pharmaceuticals, Inc., Protez Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ANTABIO and Sealife PHARMA® GMBH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ANTABIO and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy